Global Huntington's Disease Treatment Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Huntington's Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Huntington's Disease Treatment.
The Huntington's Disease Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Huntington's Disease Treatment market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Huntington's Disease Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Huntington's Disease Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Huntington's Disease Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The Huntington's Disease Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Huntington's Disease Treatment market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Huntington's Disease Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
- AInylam Pharmaceuticals Inc
- AmpliPhi Biosciences Corp
- Ceregene Inc
- Lundbeck
- Prana Biotechnology Limited
- Teva Pharmaceutical Industries Ltd
- Cortex Pharmaceuticals Inc
- Vertex Pharmaceuticals Incorporated
- Auspex Pharmaceuticals
- SOM Biotech
- GlaxoSmithKline
- Siena Biotech
- Raptor Pharmaceutical
- Pfizer
- Palobiofarma
- Omeros
- Ipsen
- Valeant Pharmaceuticals International Inc
- Tetrabenazine
- Selective Serotonin Reuptake Inhibitor
- Chlorpromazine
- Haloperidol
- Risperidone
- Olanzapine
- Clozapine
- Other
- Hospital
- Specialty Clinic
- other
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Southeast Asia
- Latin America
- Mexico
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Huntington's Disease Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Huntington's Disease Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 HUNTINGTON'S DISEASE TREATMENT MARKET OVERVIEW
1.1 Product Overview and Scope of Huntington's Disease Treatment
1.2 Huntington's Disease Treatment Segment by Type
1.2.1 Global Huntington's Disease Treatment Market Value Comparison by Type (2023-2029)
1.2.2 Tetrabenazine
1.2.3 Selective Serotonin Reuptake Inhibitor
1.2.4 Chlorpromazine
1.2.5 Haloperidol
1.2.6 Risperidone
1.2.7 Olanzapine
1.2.8 Clozapine
1.2.9 Other
1.3 Huntington's Disease Treatment Segment by Application
1.3.1 Global Huntington's Disease Treatment Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 other
1.4 Global Huntington's Disease Treatment Market Size Estimates and Forecasts
1.4.1 Global Huntington's Disease Treatment Revenue 2018-2029
1.4.2 Global Huntington's Disease Treatment Sales 2018-2029
1.4.3 Global Huntington's Disease Treatment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 HUNTINGTON'S DISEASE TREATMENT MARKET COMPETITION BY MANUFACTURERS
2.1 Global Huntington's Disease Treatment Sales Market Share by Manufacturers (2018-2023)
2.2 Global Huntington's Disease Treatment Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Huntington's Disease Treatment Average Price by Manufacturers (2018-2023)
2.4 Global Huntington's Disease Treatment Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Huntington's Disease Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Huntington's Disease Treatment, Product Type & Application
2.7 Huntington's Disease Treatment Market Competitive Situation and Trends
2.7.1 Huntington's Disease Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Huntington's Disease Treatment Players Market Share by Revenue
2.7.3 Global Huntington's Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 HUNTINGTON'S DISEASE TREATMENT RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Huntington's Disease Treatment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Huntington's Disease Treatment Global Huntington's Disease Treatment Sales by Region: 2018-2029
3.2.1 Global Huntington's Disease Treatment Sales by Region: 2018-2023
3.2.2 Global Huntington's Disease Treatment Sales by Region: 2024-2029
3.3 Global Huntington's Disease Treatment Global Huntington's Disease Treatment Revenue by Region: 2018-2029
3.3.1 Global Huntington's Disease Treatment Revenue by Region: 2018-2023
3.3.2 Global Huntington's Disease Treatment Revenue by Region: 2024-2029
3.4 North America Huntington's Disease Treatment Market Facts & Figures by Country
3.4.1 North America Huntington's Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Huntington's Disease Treatment Sales by Country (2018-2029)
3.4.3 North America Huntington's Disease Treatment Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Huntington's Disease Treatment Market Facts & Figures by Country
3.5.1 Europe Huntington's Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Huntington's Disease Treatment Sales by Country (2018-2029)
3.5.3 Europe Huntington's Disease Treatment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Huntington's Disease Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Huntington's Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Huntington's Disease Treatment Sales by Country (2018-2029)
3.6.3 Asia Pacific Huntington's Disease Treatment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Huntington's Disease Treatment Market Facts & Figures by Country
3.7.1 Latin America Huntington's Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Huntington's Disease Treatment Sales by Country (2018-2029)
3.7.3 Latin America Huntington's Disease Treatment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Huntington's Disease Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Huntington's Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Huntington's Disease Treatment Sales by Country (2018-2029)
3.8.3 Middle East and Africa Huntington's Disease Treatment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Huntington's Disease Treatment Sales by Type (2018-2029)
4.1.1 Global Huntington's Disease Treatment Sales by Type (2018-2023)
4.1.2 Global Huntington's Disease Treatment Sales by Type (2024-2029)
4.1.3 Global Huntington's Disease Treatment Sales Market Share by Type (2018-2029)
4.2 Global Huntington's Disease Treatment Revenue by Type (2018-2029)
4.2.1 Global Huntington's Disease Treatment Revenue by Type (2018-2023)
4.2.2 Global Huntington's Disease Treatment Revenue by Type (2024-2029)
4.2.3 Global Huntington's Disease Treatment Revenue Market Share by Type (2018-2029)
4.3 Global Huntington's Disease Treatment Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Huntington's Disease Treatment Sales by Application (2018-2029)
5.1.1 Global Huntington's Disease Treatment Sales by Application (2018-2023)
5.1.2 Global Huntington's Disease Treatment Sales by Application (2024-2029)
5.1.3 Global Huntington's Disease Treatment Sales Market Share by Application (2018-2029)
5.2 Global Huntington's Disease Treatment Revenue by Application (2018-2029)
5.2.1 Global Huntington's Disease Treatment Revenue by Application (2018-2023)
5.2.2 Global Huntington's Disease Treatment Revenue by Application (2024-2029)
5.2.3 Global Huntington's Disease Treatment Revenue Market Share by Application (2018-2029)
5.3 Global Huntington's Disease Treatment Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 AInylam Pharmaceuticals Inc
6.1.1 AInylam Pharmaceuticals Inc Corporation Information
6.1.2 AInylam Pharmaceuticals Inc Description and Business Overview
6.1.3 AInylam Pharmaceuticals Inc Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AInylam Pharmaceuticals Inc Huntington's Disease Treatment Product Portfolio
6.1.5 AInylam Pharmaceuticals Inc Recent Developments/Updates
6.2 AmpliPhi Biosciences Corp
6.2.1 AmpliPhi Biosciences Corp Corporation Information
6.2.2 AmpliPhi Biosciences Corp Description and Business Overview
6.2.3 AmpliPhi Biosciences Corp Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AmpliPhi Biosciences Corp Huntington's Disease Treatment Product Portfolio
6.2.5 AmpliPhi Biosciences Corp Recent Developments/Updates
6.3 Ceregene Inc
6.3.1 Ceregene Inc Corporation Information
6.3.2 Ceregene Inc Description and Business Overview
6.3.3 Ceregene Inc Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ceregene Inc Huntington's Disease Treatment Product Portfolio
6.3.5 Ceregene Inc Recent Developments/Updates
6.4 Lundbeck
6.4.1 Lundbeck Corporation Information
6.4.2 Lundbeck Description and Business Overview
6.4.3 Lundbeck Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lundbeck Huntington's Disease Treatment Product Portfolio
6.4.5 Lundbeck Recent Developments/Updates
6.5 Prana Biotechnology Limited
6.5.1 Prana Biotechnology Limited Corporation Information
6.5.2 Prana Biotechnology Limited Description and Business Overview
6.5.3 Prana Biotechnology Limited Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Prana Biotechnology Limited Huntington's Disease Treatment Product Portfolio
6.5.5 Prana Biotechnology Limited Recent Developments/Updates
6.6 Teva Pharmaceutical Industries Ltd
6.6.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.6.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Product Portfolio
6.6.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.7 Cortex Pharmaceuticals Inc
6.6.1 Cortex Pharmaceuticals Inc Corporation Information
6.6.2 Cortex Pharmaceuticals Inc Description and Business Overview
6.6.3 Cortex Pharmaceuticals Inc Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cortex Pharmaceuticals Inc Huntington's Disease Treatment Product Portfolio
6.7.5 Cortex Pharmaceuticals Inc Recent Developments/Updates
6.8 Vertex Pharmaceuticals Incorporated
6.8.1 Vertex Pharmaceuticals Incorporated Corporation Information
6.8.2 Vertex Pharmaceuticals Incorporated Description and Business Overview
6.8.3 Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Product Portfolio
6.8.5 Vertex Pharmaceuticals Incorporated Recent Developments/Updates
6.9 Auspex Pharmaceuticals
6.9.1 Auspex Pharmaceuticals Corporation Information
6.9.2 Auspex Pharmaceuticals Description and Business Overview
6.9.3 Auspex Pharmaceuticals Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Auspex Pharmaceuticals Huntington's Disease Treatment Product Portfolio
6.9.5 Auspex Pharmaceuticals Recent Developments/Updates
6.10 SOM Biotech
6.10.1 SOM Biotech Corporation Information
6.10.2 SOM Biotech Description and Business Overview
6.10.3 SOM Biotech Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.10.4 SOM Biotech Huntington's Disease Treatment Product Portfolio
6.10.5 SOM Biotech Recent Developments/Updates
6.11 GlaxoSmithKline
6.11.1 GlaxoSmithKline Corporation Information
6.11.2 GlaxoSmithKline Huntington's Disease Treatment Description and Business Overview
6.11.3 GlaxoSmithKline Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.11.4 GlaxoSmithKline Huntington's Disease Treatment Product Portfolio
6.11.5 GlaxoSmithKline Recent Developments/Updates
6.12 Siena Biotech
6.12.1 Siena Biotech Corporation Information
6.12.2 Siena Biotech Huntington's Disease Treatment Description and Business Overview
6.12.3 Siena Biotech Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Siena Biotech Huntington's Disease Treatment Product Portfolio
6.12.5 Siena Biotech Recent Developments/Updates
6.13 Raptor Pharmaceutical
6.13.1 Raptor Pharmaceutical Corporation Information
6.13.2 Raptor Pharmaceutical Huntington's Disease Treatment Description and Business Overview
6.13.3 Raptor Pharmaceutical Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Raptor Pharmaceutical Huntington's Disease Treatment Product Portfolio
6.13.5 Raptor Pharmaceutical Recent Developments/Updates
6.14 Pfizer
6.14.1 Pfizer Corporation Information
6.14.2 Pfizer Huntington's Disease Treatment Description and Business Overview
6.14.3 Pfizer Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Pfizer Huntington's Disease Treatment Product Portfolio
6.14.5 Pfizer Recent Developments/Updates
6.15 Palobiofarma
6.15.1 Palobiofarma Corporation Information
6.15.2 Palobiofarma Huntington's Disease Treatment Description and Business Overview
6.15.3 Palobiofarma Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Palobiofarma Huntington's Disease Treatment Product Portfolio
6.15.5 Palobiofarma Recent Developments/Updates
6.16 Omeros
6.16.1 Omeros Corporation Information
6.16.2 Omeros Huntington's Disease Treatment Description and Business Overview
6.16.3 Omeros Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Omeros Huntington's Disease Treatment Product Portfolio
6.16.5 Omeros Recent Developments/Updates
6.17 Ipsen
6.17.1 Ipsen Corporation Information
6.17.2 Ipsen Huntington's Disease Treatment Description and Business Overview
6.17.3 Ipsen Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Ipsen Huntington's Disease Treatment Product Portfolio
6.17.5 Ipsen Recent Developments/Updates
6.18 Valeant Pharmaceuticals International Inc
6.18.1 Valeant Pharmaceuticals International Inc Corporation Information
6.18.2 Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Description and Business Overview
6.18.3 Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Product Portfolio
6.18.5 Valeant Pharmaceuticals International Inc Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Huntington's Disease Treatment Industry Chain Analysis
7.2 Huntington's Disease Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Huntington's Disease Treatment Production Mode & Process
7.4 Huntington's Disease Treatment Sales and Marketing
7.4.1 Huntington's Disease Treatment Sales Channels
7.4.2 Huntington's Disease Treatment Distributors
7.5 Huntington's Disease Treatment Customers
8 HUNTINGTON'S DISEASE TREATMENT MARKET DYNAMICS
8.1 Huntington's Disease Treatment Industry Trends
8.2 Huntington's Disease Treatment Market Drivers
8.3 Huntington's Disease Treatment Market Challenges
8.4 Huntington's Disease Treatment Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Huntington's Disease Treatment
1.2 Huntington's Disease Treatment Segment by Type
1.2.1 Global Huntington's Disease Treatment Market Value Comparison by Type (2023-2029)
1.2.2 Tetrabenazine
1.2.3 Selective Serotonin Reuptake Inhibitor
1.2.4 Chlorpromazine
1.2.5 Haloperidol
1.2.6 Risperidone
1.2.7 Olanzapine
1.2.8 Clozapine
1.2.9 Other
1.3 Huntington's Disease Treatment Segment by Application
1.3.1 Global Huntington's Disease Treatment Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 other
1.4 Global Huntington's Disease Treatment Market Size Estimates and Forecasts
1.4.1 Global Huntington's Disease Treatment Revenue 2018-2029
1.4.2 Global Huntington's Disease Treatment Sales 2018-2029
1.4.3 Global Huntington's Disease Treatment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 HUNTINGTON'S DISEASE TREATMENT MARKET COMPETITION BY MANUFACTURERS
2.1 Global Huntington's Disease Treatment Sales Market Share by Manufacturers (2018-2023)
2.2 Global Huntington's Disease Treatment Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Huntington's Disease Treatment Average Price by Manufacturers (2018-2023)
2.4 Global Huntington's Disease Treatment Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Huntington's Disease Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Huntington's Disease Treatment, Product Type & Application
2.7 Huntington's Disease Treatment Market Competitive Situation and Trends
2.7.1 Huntington's Disease Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Huntington's Disease Treatment Players Market Share by Revenue
2.7.3 Global Huntington's Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 HUNTINGTON'S DISEASE TREATMENT RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Huntington's Disease Treatment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Huntington's Disease Treatment Global Huntington's Disease Treatment Sales by Region: 2018-2029
3.2.1 Global Huntington's Disease Treatment Sales by Region: 2018-2023
3.2.2 Global Huntington's Disease Treatment Sales by Region: 2024-2029
3.3 Global Huntington's Disease Treatment Global Huntington's Disease Treatment Revenue by Region: 2018-2029
3.3.1 Global Huntington's Disease Treatment Revenue by Region: 2018-2023
3.3.2 Global Huntington's Disease Treatment Revenue by Region: 2024-2029
3.4 North America Huntington's Disease Treatment Market Facts & Figures by Country
3.4.1 North America Huntington's Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Huntington's Disease Treatment Sales by Country (2018-2029)
3.4.3 North America Huntington's Disease Treatment Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Huntington's Disease Treatment Market Facts & Figures by Country
3.5.1 Europe Huntington's Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Huntington's Disease Treatment Sales by Country (2018-2029)
3.5.3 Europe Huntington's Disease Treatment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Huntington's Disease Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Huntington's Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Huntington's Disease Treatment Sales by Country (2018-2029)
3.6.3 Asia Pacific Huntington's Disease Treatment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Huntington's Disease Treatment Market Facts & Figures by Country
3.7.1 Latin America Huntington's Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Huntington's Disease Treatment Sales by Country (2018-2029)
3.7.3 Latin America Huntington's Disease Treatment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Huntington's Disease Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Huntington's Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Huntington's Disease Treatment Sales by Country (2018-2029)
3.8.3 Middle East and Africa Huntington's Disease Treatment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Huntington's Disease Treatment Sales by Type (2018-2029)
4.1.1 Global Huntington's Disease Treatment Sales by Type (2018-2023)
4.1.2 Global Huntington's Disease Treatment Sales by Type (2024-2029)
4.1.3 Global Huntington's Disease Treatment Sales Market Share by Type (2018-2029)
4.2 Global Huntington's Disease Treatment Revenue by Type (2018-2029)
4.2.1 Global Huntington's Disease Treatment Revenue by Type (2018-2023)
4.2.2 Global Huntington's Disease Treatment Revenue by Type (2024-2029)
4.2.3 Global Huntington's Disease Treatment Revenue Market Share by Type (2018-2029)
4.3 Global Huntington's Disease Treatment Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Huntington's Disease Treatment Sales by Application (2018-2029)
5.1.1 Global Huntington's Disease Treatment Sales by Application (2018-2023)
5.1.2 Global Huntington's Disease Treatment Sales by Application (2024-2029)
5.1.3 Global Huntington's Disease Treatment Sales Market Share by Application (2018-2029)
5.2 Global Huntington's Disease Treatment Revenue by Application (2018-2029)
5.2.1 Global Huntington's Disease Treatment Revenue by Application (2018-2023)
5.2.2 Global Huntington's Disease Treatment Revenue by Application (2024-2029)
5.2.3 Global Huntington's Disease Treatment Revenue Market Share by Application (2018-2029)
5.3 Global Huntington's Disease Treatment Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 AInylam Pharmaceuticals Inc
6.1.1 AInylam Pharmaceuticals Inc Corporation Information
6.1.2 AInylam Pharmaceuticals Inc Description and Business Overview
6.1.3 AInylam Pharmaceuticals Inc Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AInylam Pharmaceuticals Inc Huntington's Disease Treatment Product Portfolio
6.1.5 AInylam Pharmaceuticals Inc Recent Developments/Updates
6.2 AmpliPhi Biosciences Corp
6.2.1 AmpliPhi Biosciences Corp Corporation Information
6.2.2 AmpliPhi Biosciences Corp Description and Business Overview
6.2.3 AmpliPhi Biosciences Corp Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AmpliPhi Biosciences Corp Huntington's Disease Treatment Product Portfolio
6.2.5 AmpliPhi Biosciences Corp Recent Developments/Updates
6.3 Ceregene Inc
6.3.1 Ceregene Inc Corporation Information
6.3.2 Ceregene Inc Description and Business Overview
6.3.3 Ceregene Inc Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ceregene Inc Huntington's Disease Treatment Product Portfolio
6.3.5 Ceregene Inc Recent Developments/Updates
6.4 Lundbeck
6.4.1 Lundbeck Corporation Information
6.4.2 Lundbeck Description and Business Overview
6.4.3 Lundbeck Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lundbeck Huntington's Disease Treatment Product Portfolio
6.4.5 Lundbeck Recent Developments/Updates
6.5 Prana Biotechnology Limited
6.5.1 Prana Biotechnology Limited Corporation Information
6.5.2 Prana Biotechnology Limited Description and Business Overview
6.5.3 Prana Biotechnology Limited Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Prana Biotechnology Limited Huntington's Disease Treatment Product Portfolio
6.5.5 Prana Biotechnology Limited Recent Developments/Updates
6.6 Teva Pharmaceutical Industries Ltd
6.6.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.6.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Product Portfolio
6.6.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.7 Cortex Pharmaceuticals Inc
6.6.1 Cortex Pharmaceuticals Inc Corporation Information
6.6.2 Cortex Pharmaceuticals Inc Description and Business Overview
6.6.3 Cortex Pharmaceuticals Inc Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cortex Pharmaceuticals Inc Huntington's Disease Treatment Product Portfolio
6.7.5 Cortex Pharmaceuticals Inc Recent Developments/Updates
6.8 Vertex Pharmaceuticals Incorporated
6.8.1 Vertex Pharmaceuticals Incorporated Corporation Information
6.8.2 Vertex Pharmaceuticals Incorporated Description and Business Overview
6.8.3 Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Product Portfolio
6.8.5 Vertex Pharmaceuticals Incorporated Recent Developments/Updates
6.9 Auspex Pharmaceuticals
6.9.1 Auspex Pharmaceuticals Corporation Information
6.9.2 Auspex Pharmaceuticals Description and Business Overview
6.9.3 Auspex Pharmaceuticals Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Auspex Pharmaceuticals Huntington's Disease Treatment Product Portfolio
6.9.5 Auspex Pharmaceuticals Recent Developments/Updates
6.10 SOM Biotech
6.10.1 SOM Biotech Corporation Information
6.10.2 SOM Biotech Description and Business Overview
6.10.3 SOM Biotech Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.10.4 SOM Biotech Huntington's Disease Treatment Product Portfolio
6.10.5 SOM Biotech Recent Developments/Updates
6.11 GlaxoSmithKline
6.11.1 GlaxoSmithKline Corporation Information
6.11.2 GlaxoSmithKline Huntington's Disease Treatment Description and Business Overview
6.11.3 GlaxoSmithKline Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.11.4 GlaxoSmithKline Huntington's Disease Treatment Product Portfolio
6.11.5 GlaxoSmithKline Recent Developments/Updates
6.12 Siena Biotech
6.12.1 Siena Biotech Corporation Information
6.12.2 Siena Biotech Huntington's Disease Treatment Description and Business Overview
6.12.3 Siena Biotech Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Siena Biotech Huntington's Disease Treatment Product Portfolio
6.12.5 Siena Biotech Recent Developments/Updates
6.13 Raptor Pharmaceutical
6.13.1 Raptor Pharmaceutical Corporation Information
6.13.2 Raptor Pharmaceutical Huntington's Disease Treatment Description and Business Overview
6.13.3 Raptor Pharmaceutical Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Raptor Pharmaceutical Huntington's Disease Treatment Product Portfolio
6.13.5 Raptor Pharmaceutical Recent Developments/Updates
6.14 Pfizer
6.14.1 Pfizer Corporation Information
6.14.2 Pfizer Huntington's Disease Treatment Description and Business Overview
6.14.3 Pfizer Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Pfizer Huntington's Disease Treatment Product Portfolio
6.14.5 Pfizer Recent Developments/Updates
6.15 Palobiofarma
6.15.1 Palobiofarma Corporation Information
6.15.2 Palobiofarma Huntington's Disease Treatment Description and Business Overview
6.15.3 Palobiofarma Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Palobiofarma Huntington's Disease Treatment Product Portfolio
6.15.5 Palobiofarma Recent Developments/Updates
6.16 Omeros
6.16.1 Omeros Corporation Information
6.16.2 Omeros Huntington's Disease Treatment Description and Business Overview
6.16.3 Omeros Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Omeros Huntington's Disease Treatment Product Portfolio
6.16.5 Omeros Recent Developments/Updates
6.17 Ipsen
6.17.1 Ipsen Corporation Information
6.17.2 Ipsen Huntington's Disease Treatment Description and Business Overview
6.17.3 Ipsen Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Ipsen Huntington's Disease Treatment Product Portfolio
6.17.5 Ipsen Recent Developments/Updates
6.18 Valeant Pharmaceuticals International Inc
6.18.1 Valeant Pharmaceuticals International Inc Corporation Information
6.18.2 Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Description and Business Overview
6.18.3 Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Product Portfolio
6.18.5 Valeant Pharmaceuticals International Inc Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Huntington's Disease Treatment Industry Chain Analysis
7.2 Huntington's Disease Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Huntington's Disease Treatment Production Mode & Process
7.4 Huntington's Disease Treatment Sales and Marketing
7.4.1 Huntington's Disease Treatment Sales Channels
7.4.2 Huntington's Disease Treatment Distributors
7.5 Huntington's Disease Treatment Customers
8 HUNTINGTON'S DISEASE TREATMENT MARKET DYNAMICS
8.1 Huntington's Disease Treatment Industry Trends
8.2 Huntington's Disease Treatment Market Drivers
8.3 Huntington's Disease Treatment Market Challenges
8.4 Huntington's Disease Treatment Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Huntington's Disease Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Huntington's Disease Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Huntington's Disease Treatment Market Competitive Situation by Manufacturers in 2022
Table 4. Global Huntington's Disease Treatment Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Huntington's Disease Treatment Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Huntington's Disease Treatment Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Huntington's Disease Treatment Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Huntington's Disease Treatment Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Huntington's Disease Treatment, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Huntington's Disease Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Huntington's Disease Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Huntington's Disease Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Huntington's Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Huntington's Disease Treatment as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Huntington's Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Huntington's Disease Treatment Sales by Region (2018-2023) & (K Units)
Table 18. Global Huntington's Disease Treatment Sales Market Share by Region (2018-2023)
Table 19. Global Huntington's Disease Treatment Sales by Region (2024-2029) & (K Units)
Table 20. Global Huntington's Disease Treatment Sales Market Share by Region (2024-2029)
Table 21. Global Huntington's Disease Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Huntington's Disease Treatment Revenue Market Share by Region (2018-2023)
Table 23. Global Huntington's Disease Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Huntington's Disease Treatment Revenue Market Share by Region (2024-2029)
Table 25. North America Huntington's Disease Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Huntington's Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 27. North America Huntington's Disease Treatment Sales by Country (2024-2029) & (K Units)
Table 28. North America Huntington's Disease Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Huntington's Disease Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Huntington's Disease Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Huntington's Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 32. Europe Huntington's Disease Treatment Sales by Country (2024-2029) & (K Units)
Table 33. Europe Huntington's Disease Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Huntington's Disease Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Huntington's Disease Treatment Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Huntington's Disease Treatment Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Huntington's Disease Treatment Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Huntington's Disease Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Huntington's Disease Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Huntington's Disease Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Huntington's Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Huntington's Disease Treatment Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Huntington's Disease Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Huntington's Disease Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Huntington's Disease Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Huntington's Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Huntington's Disease Treatment Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Huntington's Disease Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Huntington's Disease Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Huntington's Disease Treatment Sales (K Units) by Type (2018-2023)
Table 51. Global Huntington's Disease Treatment Sales (K Units) by Type (2024-2029)
Table 52. Global Huntington's Disease Treatment Sales Market Share by Type (2018-2023)
Table 53. Global Huntington's Disease Treatment Sales Market Share by Type (2024-2029)
Table 54. Global Huntington's Disease Treatment Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Huntington's Disease Treatment Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Huntington's Disease Treatment Revenue Market Share by Type (2018-2023)
Table 57. Global Huntington's Disease Treatment Revenue Market Share by Type (2024-2029)
Table 58. Global Huntington's Disease Treatment Price (US$/Unit) by Type (2018-2023)
Table 59. Global Huntington's Disease Treatment Price (US$/Unit) by Type (2024-2029)
Table 60. Global Huntington's Disease Treatment Sales (K Units) by Application (2018-2023)
Table 61. Global Huntington's Disease Treatment Sales (K Units) by Application (2024-2029)
Table 62. Global Huntington's Disease Treatment Sales Market Share by Application (2018-2023)
Table 63. Global Huntington's Disease Treatment Sales Market Share by Application (2024-2029)
Table 64. Global Huntington's Disease Treatment Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Huntington's Disease Treatment Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Huntington's Disease Treatment Revenue Market Share by Application (2018-2023)
Table 67. Global Huntington's Disease Treatment Revenue Market Share by Application (2024-2029)
Table 68. Global Huntington's Disease Treatment Price (US$/Unit) by Application (2018-2023)
Table 69. Global Huntington's Disease Treatment Price (US$/Unit) by Application (2024-2029)
Table 70. AInylam Pharmaceuticals Inc Corporation Information
Table 71. AInylam Pharmaceuticals Inc Description and Business Overview
Table 72. AInylam Pharmaceuticals Inc Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. AInylam Pharmaceuticals Inc Huntington's Disease Treatment Product
Table 74. AInylam Pharmaceuticals Inc Recent Developments/Updates
Table 75. AmpliPhi Biosciences Corp Corporation Information
Table 76. AmpliPhi Biosciences Corp Description and Business Overview
Table 77. AmpliPhi Biosciences Corp Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. AmpliPhi Biosciences Corp Huntington's Disease Treatment Product
Table 79. AmpliPhi Biosciences Corp Recent Developments/Updates
Table 80. Ceregene Inc Corporation Information
Table 81. Ceregene Inc Description and Business Overview
Table 82. Ceregene Inc Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Ceregene Inc Huntington's Disease Treatment Product
Table 84. Ceregene Inc Recent Developments/Updates
Table 85. Lundbeck Corporation Information
Table 86. Lundbeck Description and Business Overview
Table 87. Lundbeck Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Lundbeck Huntington's Disease Treatment Product
Table 89. Lundbeck Recent Developments/Updates
Table 90. Prana Biotechnology Limited Corporation Information
Table 91. Prana Biotechnology Limited Description and Business Overview
Table 92. Prana Biotechnology Limited Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Prana Biotechnology Limited Huntington's Disease Treatment Product
Table 94. Prana Biotechnology Limited Recent Developments/Updates
Table 95. Teva Pharmaceutical Industries Ltd Corporation Information
Table 96. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 97. Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Product
Table 99. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 100. Cortex Pharmaceuticals Inc Corporation Information
Table 101. Cortex Pharmaceuticals Inc Description and Business Overview
Table 102. Cortex Pharmaceuticals Inc Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Cortex Pharmaceuticals Inc Huntington's Disease Treatment Product
Table 104. Cortex Pharmaceuticals Inc Recent Developments/Updates
Table 105. Vertex Pharmaceuticals Incorporated Corporation Information
Table 106. Vertex Pharmaceuticals Incorporated Description and Business Overview
Table 107. Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Product
Table 109. Vertex Pharmaceuticals Incorporated Recent Developments/Updates
Table 110. Auspex Pharmaceuticals Corporation Information
Table 111. Auspex Pharmaceuticals Description and Business Overview
Table 112. Auspex Pharmaceuticals Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Auspex Pharmaceuticals Huntington's Disease Treatment Product
Table 114. Auspex Pharmaceuticals Recent Developments/Updates
Table 115. SOM Biotech Corporation Information
Table 116. SOM Biotech Description and Business Overview
Table 117. SOM Biotech Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. SOM Biotech Huntington's Disease Treatment Product
Table 119. SOM Biotech Recent Developments/Updates
Table 120. GlaxoSmithKline Corporation Information
Table 121. GlaxoSmithKline Description and Business Overview
Table 122. GlaxoSmithKline Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. GlaxoSmithKline Huntington's Disease Treatment Product
Table 124. GlaxoSmithKline Recent Developments/Updates
Table 125. Siena Biotech Corporation Information
Table 126. Siena Biotech Description and Business Overview
Table 127. Siena Biotech Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Siena Biotech Huntington's Disease Treatment Product
Table 129. Siena Biotech Recent Developments/Updates
Table 130. Raptor Pharmaceutical Corporation Information
Table 131. Raptor Pharmaceutical Description and Business Overview
Table 132. Raptor Pharmaceutical Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Raptor Pharmaceutical Huntington's Disease Treatment Product
Table 134. Raptor Pharmaceutical Recent Developments/Updates
Table 135. Pfizer Corporation Information
Table 136. Pfizer Description and Business Overview
Table 137. Pfizer Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Pfizer Huntington's Disease Treatment Product
Table 139. Pfizer Recent Developments/Updates
Table 140. Palobiofarma Corporation Information
Table 141. Palobiofarma Description and Business Overview
Table 142. Palobiofarma Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Palobiofarma Huntington's Disease Treatment Product
Table 144. Palobiofarma Recent Developments/Updates
Table 145. Omeros Corporation Information
Table 146. Omeros Description and Business Overview
Table 147. Omeros Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Omeros Huntington's Disease Treatment Product
Table 149. Omeros Recent Developments/Updates
Table 150. Ipsen Corporation Information
Table 151. Ipsen Description and Business Overview
Table 152. Ipsen Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Ipsen Huntington's Disease Treatment Product
Table 154. Ipsen Recent Developments/Updates
Table 155. Valeant Pharmaceuticals International Inc Corporation Information
Table 156. Valeant Pharmaceuticals International Inc Description and Business Overview
Table 157. Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Product
Table 159. Valeant Pharmaceuticals International Inc Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Huntington's Disease Treatment Distributors List
Table 163. Huntington's Disease Treatment Customers List
Table 164. Huntington's Disease Treatment Market Trends
Table 165. Huntington's Disease Treatment Market Drivers
Table 166. Huntington's Disease Treatment Market Challenges
Table 167. Huntington's Disease Treatment Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 1. Global Huntington's Disease Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Huntington's Disease Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Huntington's Disease Treatment Market Competitive Situation by Manufacturers in 2022
Table 4. Global Huntington's Disease Treatment Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Huntington's Disease Treatment Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Huntington's Disease Treatment Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Huntington's Disease Treatment Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Huntington's Disease Treatment Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Huntington's Disease Treatment, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Huntington's Disease Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Huntington's Disease Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Huntington's Disease Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Huntington's Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Huntington's Disease Treatment as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Huntington's Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Huntington's Disease Treatment Sales by Region (2018-2023) & (K Units)
Table 18. Global Huntington's Disease Treatment Sales Market Share by Region (2018-2023)
Table 19. Global Huntington's Disease Treatment Sales by Region (2024-2029) & (K Units)
Table 20. Global Huntington's Disease Treatment Sales Market Share by Region (2024-2029)
Table 21. Global Huntington's Disease Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Huntington's Disease Treatment Revenue Market Share by Region (2018-2023)
Table 23. Global Huntington's Disease Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Huntington's Disease Treatment Revenue Market Share by Region (2024-2029)
Table 25. North America Huntington's Disease Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Huntington's Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 27. North America Huntington's Disease Treatment Sales by Country (2024-2029) & (K Units)
Table 28. North America Huntington's Disease Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Huntington's Disease Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Huntington's Disease Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Huntington's Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 32. Europe Huntington's Disease Treatment Sales by Country (2024-2029) & (K Units)
Table 33. Europe Huntington's Disease Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Huntington's Disease Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Huntington's Disease Treatment Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Huntington's Disease Treatment Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Huntington's Disease Treatment Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Huntington's Disease Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Huntington's Disease Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Huntington's Disease Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Huntington's Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Huntington's Disease Treatment Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Huntington's Disease Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Huntington's Disease Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Huntington's Disease Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Huntington's Disease Treatment Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Huntington's Disease Treatment Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Huntington's Disease Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Huntington's Disease Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Huntington's Disease Treatment Sales (K Units) by Type (2018-2023)
Table 51. Global Huntington's Disease Treatment Sales (K Units) by Type (2024-2029)
Table 52. Global Huntington's Disease Treatment Sales Market Share by Type (2018-2023)
Table 53. Global Huntington's Disease Treatment Sales Market Share by Type (2024-2029)
Table 54. Global Huntington's Disease Treatment Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Huntington's Disease Treatment Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Huntington's Disease Treatment Revenue Market Share by Type (2018-2023)
Table 57. Global Huntington's Disease Treatment Revenue Market Share by Type (2024-2029)
Table 58. Global Huntington's Disease Treatment Price (US$/Unit) by Type (2018-2023)
Table 59. Global Huntington's Disease Treatment Price (US$/Unit) by Type (2024-2029)
Table 60. Global Huntington's Disease Treatment Sales (K Units) by Application (2018-2023)
Table 61. Global Huntington's Disease Treatment Sales (K Units) by Application (2024-2029)
Table 62. Global Huntington's Disease Treatment Sales Market Share by Application (2018-2023)
Table 63. Global Huntington's Disease Treatment Sales Market Share by Application (2024-2029)
Table 64. Global Huntington's Disease Treatment Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Huntington's Disease Treatment Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Huntington's Disease Treatment Revenue Market Share by Application (2018-2023)
Table 67. Global Huntington's Disease Treatment Revenue Market Share by Application (2024-2029)
Table 68. Global Huntington's Disease Treatment Price (US$/Unit) by Application (2018-2023)
Table 69. Global Huntington's Disease Treatment Price (US$/Unit) by Application (2024-2029)
Table 70. AInylam Pharmaceuticals Inc Corporation Information
Table 71. AInylam Pharmaceuticals Inc Description and Business Overview
Table 72. AInylam Pharmaceuticals Inc Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. AInylam Pharmaceuticals Inc Huntington's Disease Treatment Product
Table 74. AInylam Pharmaceuticals Inc Recent Developments/Updates
Table 75. AmpliPhi Biosciences Corp Corporation Information
Table 76. AmpliPhi Biosciences Corp Description and Business Overview
Table 77. AmpliPhi Biosciences Corp Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. AmpliPhi Biosciences Corp Huntington's Disease Treatment Product
Table 79. AmpliPhi Biosciences Corp Recent Developments/Updates
Table 80. Ceregene Inc Corporation Information
Table 81. Ceregene Inc Description and Business Overview
Table 82. Ceregene Inc Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Ceregene Inc Huntington's Disease Treatment Product
Table 84. Ceregene Inc Recent Developments/Updates
Table 85. Lundbeck Corporation Information
Table 86. Lundbeck Description and Business Overview
Table 87. Lundbeck Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Lundbeck Huntington's Disease Treatment Product
Table 89. Lundbeck Recent Developments/Updates
Table 90. Prana Biotechnology Limited Corporation Information
Table 91. Prana Biotechnology Limited Description and Business Overview
Table 92. Prana Biotechnology Limited Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Prana Biotechnology Limited Huntington's Disease Treatment Product
Table 94. Prana Biotechnology Limited Recent Developments/Updates
Table 95. Teva Pharmaceutical Industries Ltd Corporation Information
Table 96. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 97. Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Teva Pharmaceutical Industries Ltd Huntington's Disease Treatment Product
Table 99. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 100. Cortex Pharmaceuticals Inc Corporation Information
Table 101. Cortex Pharmaceuticals Inc Description and Business Overview
Table 102. Cortex Pharmaceuticals Inc Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Cortex Pharmaceuticals Inc Huntington's Disease Treatment Product
Table 104. Cortex Pharmaceuticals Inc Recent Developments/Updates
Table 105. Vertex Pharmaceuticals Incorporated Corporation Information
Table 106. Vertex Pharmaceuticals Incorporated Description and Business Overview
Table 107. Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Vertex Pharmaceuticals Incorporated Huntington's Disease Treatment Product
Table 109. Vertex Pharmaceuticals Incorporated Recent Developments/Updates
Table 110. Auspex Pharmaceuticals Corporation Information
Table 111. Auspex Pharmaceuticals Description and Business Overview
Table 112. Auspex Pharmaceuticals Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Auspex Pharmaceuticals Huntington's Disease Treatment Product
Table 114. Auspex Pharmaceuticals Recent Developments/Updates
Table 115. SOM Biotech Corporation Information
Table 116. SOM Biotech Description and Business Overview
Table 117. SOM Biotech Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. SOM Biotech Huntington's Disease Treatment Product
Table 119. SOM Biotech Recent Developments/Updates
Table 120. GlaxoSmithKline Corporation Information
Table 121. GlaxoSmithKline Description and Business Overview
Table 122. GlaxoSmithKline Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. GlaxoSmithKline Huntington's Disease Treatment Product
Table 124. GlaxoSmithKline Recent Developments/Updates
Table 125. Siena Biotech Corporation Information
Table 126. Siena Biotech Description and Business Overview
Table 127. Siena Biotech Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Siena Biotech Huntington's Disease Treatment Product
Table 129. Siena Biotech Recent Developments/Updates
Table 130. Raptor Pharmaceutical Corporation Information
Table 131. Raptor Pharmaceutical Description and Business Overview
Table 132. Raptor Pharmaceutical Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Raptor Pharmaceutical Huntington's Disease Treatment Product
Table 134. Raptor Pharmaceutical Recent Developments/Updates
Table 135. Pfizer Corporation Information
Table 136. Pfizer Description and Business Overview
Table 137. Pfizer Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Pfizer Huntington's Disease Treatment Product
Table 139. Pfizer Recent Developments/Updates
Table 140. Palobiofarma Corporation Information
Table 141. Palobiofarma Description and Business Overview
Table 142. Palobiofarma Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Palobiofarma Huntington's Disease Treatment Product
Table 144. Palobiofarma Recent Developments/Updates
Table 145. Omeros Corporation Information
Table 146. Omeros Description and Business Overview
Table 147. Omeros Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Omeros Huntington's Disease Treatment Product
Table 149. Omeros Recent Developments/Updates
Table 150. Ipsen Corporation Information
Table 151. Ipsen Description and Business Overview
Table 152. Ipsen Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Ipsen Huntington's Disease Treatment Product
Table 154. Ipsen Recent Developments/Updates
Table 155. Valeant Pharmaceuticals International Inc Corporation Information
Table 156. Valeant Pharmaceuticals International Inc Description and Business Overview
Table 157. Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Valeant Pharmaceuticals International Inc Huntington's Disease Treatment Product
Table 159. Valeant Pharmaceuticals International Inc Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Huntington's Disease Treatment Distributors List
Table 163. Huntington's Disease Treatment Customers List
Table 164. Huntington's Disease Treatment Market Trends
Table 165. Huntington's Disease Treatment Market Drivers
Table 166. Huntington's Disease Treatment Market Challenges
Table 167. Huntington's Disease Treatment Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Huntington's Disease Treatment
Figure 2. Global Huntington's Disease Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Huntington's Disease Treatment Market Share by Type in 2022 & 2029
Figure 4. Tetrabenazine Product Picture
Figure 5. Selective Serotonin Reuptake Inhibitor Product Picture
Figure 6. Chlorpromazine Product Picture
Figure 7. Haloperidol Product Picture
Figure 8. Risperidone Product Picture
Figure 9. Olanzapine Product Picture
Figure 10. Clozapine Product Picture
Figure 11. Other Product Picture
Figure 12. Global Huntington's Disease Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 13. Global Huntington's Disease Treatment Market Share by Application in 2022 & 2029
Figure 14. Hospital
Figure 15. Specialty Clinic
Figure 16. other
Figure 17. Global Huntington's Disease Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Huntington's Disease Treatment Market Size (2018-2029) & (US$ Million)
Figure 19. Global Huntington's Disease Treatment Sales (2018-2029) & (K Units)
Figure 20. Global Huntington's Disease Treatment Average Price (US$/Unit) & (2018-2029)
Figure 21. Huntington's Disease Treatment Report Years Considered
Figure 22. Huntington's Disease Treatment Sales Share by Manufacturers in 2022
Figure 23. Global Huntington's Disease Treatment Revenue Share by Manufacturers in 2022
Figure 24. The Global 5 and 10 Largest Huntington's Disease Treatment Players: Market Share by Revenue in 2022
Figure 25. Huntington's Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 26. Global Huntington's Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 27. North America Huntington's Disease Treatment Sales Market Share by Country (2018-2029)
Figure 28. North America Huntington's Disease Treatment Revenue Market Share by Country (2018-2029)
Figure 29. United States Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Canada Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Europe Huntington's Disease Treatment Sales Market Share by Country (2018-2029)
Figure 32. Europe Huntington's Disease Treatment Revenue Market Share by Country (2018-2029)
Figure 33. Germany Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. France Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. U.K. Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Italy Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Russia Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Asia Pacific Huntington's Disease Treatment Sales Market Share by Region (2018-2029)
Figure 39. Asia Pacific Huntington's Disease Treatment Revenue Market Share by Region (2018-2029)
Figure 40. China Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Japan Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. South Korea Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. India Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Australia Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. China Taiwan Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Huntington's Disease Treatment Sales Market Share by Country (2018-2029)
Figure 48. Latin America Huntington's Disease Treatment Revenue Market Share by Country (2018-2029)
Figure 49. Mexico Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Colombia Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East & Africa Huntington's Disease Treatment Sales Market Share by Country (2018-2029)
Figure 54. Middle East & Africa Huntington's Disease Treatment Revenue Market Share by Country (2018-2029)
Figure 55. Turkey Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. UAE Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Global Sales Market Share of Huntington's Disease Treatment by Type (2018-2029)
Figure 59. Global Revenue Market Share of Huntington's Disease Treatment by Type (2018-2029)
Figure 60. Global Huntington's Disease Treatment Price (US$/Unit) by Type (2018-2029)
Figure 61. Global Sales Market Share of Huntington's Disease Treatment by Application (2018-2029)
Figure 62. Global Revenue Market Share of Huntington's Disease Treatment by Application (2018-2029)
Figure 63. Global Huntington's Disease Treatment Price (US$/Unit) by Application (2018-2029)
Figure 64. Huntington's Disease Treatment Value Chain
Figure 65. Huntington's Disease Treatment Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Figure 1. Product Picture of Huntington's Disease Treatment
Figure 2. Global Huntington's Disease Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Huntington's Disease Treatment Market Share by Type in 2022 & 2029
Figure 4. Tetrabenazine Product Picture
Figure 5. Selective Serotonin Reuptake Inhibitor Product Picture
Figure 6. Chlorpromazine Product Picture
Figure 7. Haloperidol Product Picture
Figure 8. Risperidone Product Picture
Figure 9. Olanzapine Product Picture
Figure 10. Clozapine Product Picture
Figure 11. Other Product Picture
Figure 12. Global Huntington's Disease Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 13. Global Huntington's Disease Treatment Market Share by Application in 2022 & 2029
Figure 14. Hospital
Figure 15. Specialty Clinic
Figure 16. other
Figure 17. Global Huntington's Disease Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Huntington's Disease Treatment Market Size (2018-2029) & (US$ Million)
Figure 19. Global Huntington's Disease Treatment Sales (2018-2029) & (K Units)
Figure 20. Global Huntington's Disease Treatment Average Price (US$/Unit) & (2018-2029)
Figure 21. Huntington's Disease Treatment Report Years Considered
Figure 22. Huntington's Disease Treatment Sales Share by Manufacturers in 2022
Figure 23. Global Huntington's Disease Treatment Revenue Share by Manufacturers in 2022
Figure 24. The Global 5 and 10 Largest Huntington's Disease Treatment Players: Market Share by Revenue in 2022
Figure 25. Huntington's Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 26. Global Huntington's Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 27. North America Huntington's Disease Treatment Sales Market Share by Country (2018-2029)
Figure 28. North America Huntington's Disease Treatment Revenue Market Share by Country (2018-2029)
Figure 29. United States Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Canada Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Europe Huntington's Disease Treatment Sales Market Share by Country (2018-2029)
Figure 32. Europe Huntington's Disease Treatment Revenue Market Share by Country (2018-2029)
Figure 33. Germany Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. France Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. U.K. Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Italy Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Russia Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Asia Pacific Huntington's Disease Treatment Sales Market Share by Region (2018-2029)
Figure 39. Asia Pacific Huntington's Disease Treatment Revenue Market Share by Region (2018-2029)
Figure 40. China Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Japan Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. South Korea Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. India Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Australia Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. China Taiwan Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Huntington's Disease Treatment Sales Market Share by Country (2018-2029)
Figure 48. Latin America Huntington's Disease Treatment Revenue Market Share by Country (2018-2029)
Figure 49. Mexico Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Colombia Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East & Africa Huntington's Disease Treatment Sales Market Share by Country (2018-2029)
Figure 54. Middle East & Africa Huntington's Disease Treatment Revenue Market Share by Country (2018-2029)
Figure 55. Turkey Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. UAE Huntington's Disease Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Global Sales Market Share of Huntington's Disease Treatment by Type (2018-2029)
Figure 59. Global Revenue Market Share of Huntington's Disease Treatment by Type (2018-2029)
Figure 60. Global Huntington's Disease Treatment Price (US$/Unit) by Type (2018-2029)
Figure 61. Global Sales Market Share of Huntington's Disease Treatment by Application (2018-2029)
Figure 62. Global Revenue Market Share of Huntington's Disease Treatment by Application (2018-2029)
Figure 63. Global Huntington's Disease Treatment Price (US$/Unit) by Application (2018-2029)
Figure 64. Huntington's Disease Treatment Value Chain
Figure 65. Huntington's Disease Treatment Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
